Pelizzo M R, Toniato A, Grigoletto R
Dept. of General Surgery, University of Padua.
J Exp Clin Cancer Res. 1997 Sep;16(3):261-5.
Out of 677 patients, who underwent surgery for papillary thyroid carcinoma between '67-'95, we selected for survival uni and multivariate analysis 463 patients with over 5 years of minimal follow up (max 28, mean 11.15 +/- 5.29). Patient's sex, age (over and under 45) tumour size (smaller and larger than 15 mm), stage, any TNM parameter, hystological variety, surgical procedure on the thyroid and nodes were the factors assessed in order to establish the prognosis. Male:female ratio was 1:3, average age 42.2 +/- 0.68; only 25.9% of the patients presented smaller than 15 mm tumors, about 57% positive nodes and 8.85% distant metastases; total or near total thyroidectomy was performed in 86% of the cases and nodal dissection in 68.47%. The 10, 15, 20 year survival rate resulted to be 94.36%, 91.38% and 88.69%; 23 patients (4.96%) died of poorly differentiated and locally advanced carcinoma, but none of them was younger than 45. Age over 45, T4 and M+ stage parameters and dedifferentiated histotype resulted of high value while nodal involvement, interrelated with T and M, showed no independent impact; stage gradually got worse but no difference was found between stage I and II, or T1 and T2. Surgical treatment has not resulted to affect survival, whereas lymphnodes involvement is correlated with complications. Adverse effect of male sex resulted from its interrelation with more advanced stages. A significantly higher relapse rate was found in males and in patients over 45, interrelated with T and N extension: no tumor smaller than 15 mm recurred and no relation was found between recurrence and surgical procedure. Longer follow-up is needed to compare the more conservative treatments with total thyroidectomy and nodal dissection.
在1967年至1995年间接受乳头状甲状腺癌手术的677例患者中,我们选择了463例进行生存单因素和多因素分析,这些患者至少随访5年(最长28年,平均11.15±5.29年)。评估患者的性别、年龄(45岁以上和以下)、肿瘤大小(小于和大于15mm)、分期、任何TNM参数、组织学类型、甲状腺及淋巴结的手术方式等因素以确定预后。男女比例为1:3,平均年龄42.2±0.68岁;仅25.9%的患者肿瘤小于15mm,约57%有阳性淋巴结,8.85%有远处转移;86%的病例进行了全甲状腺切除或近全甲状腺切除,68.47%进行了淋巴结清扫。10年、15年、20年生存率分别为94.36%、91.38%和88.69%;23例患者(4.96%)死于低分化和局部晚期癌,但均不小于45岁。45岁以上、T4和M+分期参数以及去分化组织学类型具有较高的预后价值,而与T和M相关的淋巴结受累未显示出独立影响;分期逐渐变差,但I期与II期之间或T1与T2之间未发现差异。手术治疗未影响生存率,而淋巴结受累与并发症相关。男性的不良影响源于其与更晚期别相关。男性和45岁以上患者的复发率明显更高,与T和N的扩展相关:小于15mm的肿瘤无复发,复发与手术方式无关。需要更长时间的随访来比较更保守的治疗方法与全甲状腺切除和淋巴结清扫的效果。